Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

被引:633
|
作者
Moslehi, Javid J. [1 ,2 ,3 ]
Salem, Joe-Elie [1 ,3 ,4 ]
Sosman, Jeffrey A. [5 ,6 ]
Lebrun-Vignes, Benedicte [4 ]
Johnson, Douglas B. [2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Div Oncol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Med, Cardiooncol Program, Nashville, TN 37232 USA
[4] UPMC Univ Paris 06, Pitie Salpetriere Hosp, AP HP,UMR ICAN 1166,Sorbonne Univ,Fac Med,ICAN, Dept Pharmacol,CIC 1421,Pharmacovigilance Unit,IN, Paris, France
[5] Northwestern Univ, Dept Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA
来源
LANCET | 2018年 / 391卷 / 10124期
关键词
CARDIOTOXICITY;
D O I
10.1016/S0140-6736(18)30533-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:933 / 933
页数:1
相关论文
共 50 条
  • [1] Reporting of immune checkpoint inhibitor-associated myocarditis
    Al-Kindi, Sadeer G.
    Oliveira, Guilherme H.
    LANCET, 2018, 392 (10145): : 382 - 383
  • [2] Reporting of immune checkpoint inhibitor-associated myocarditis Reply
    Moslehi, Javid J.
    Salem, Joe-Elie
    Sosman, Jeffrey A.
    Lebrun-Vignes, Benedicte
    Johnson, Douglas B.
    LANCET, 2018, 392 (10145): : 384 - 385
  • [3] Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes
    Wright, Jordan J.
    Salem, Joe-Elie
    Johnson, Douglas B.
    Lebrun-Vignes, Benedicte
    Stamatouli, Angeliki
    Thomas, James W.
    Herold, Kevan C.
    Moslehi, Javid
    Powers, Alvin C.
    DIABETES CARE, 2018, 41 (12) : E150 - E151
  • [4] Immune Checkpoint Inhibitor-Associated Myocarditis
    Ganatra, Sarju
    Neilan, Tomas G.
    ONCOLOGIST, 2018, 23 (08): : 879 - 886
  • [5] Treatment of Immune Checkpoint Inhibitor-associated Myocarditis
    Heemelaar, Julius C.
    Louisa, Maria
    Neilan, Tomas G.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (05) : 384 - 391
  • [6] Asymptomatic Immune Checkpoint Inhibitor-associated Myocarditis
    Tanabe, Junya
    Watanabe, Nobuhide
    Endo, Akihiro
    Nagami, Taichi
    Inagaki, Satoshi
    Tanabe, Kazuaki
    INTERNAL MEDICINE, 2021, 60 (04) : 569 - 573
  • [7] IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED FULMINANT MYOCARDITIS
    Yan, Crystal L.
    Rodriguez, Beatriz P. Rivera
    Lopez, Juan
    Martinez, Moises Vasquez
    Andrade-Bucknor, Sharon N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3457 - 3457
  • [8] IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS: A CASE REPORT
    Saeed, Mariam
    Khan, Zinobia
    Bachan, Moses
    Raju, Bindu
    Khan, Muneer
    CRITICAL CARE MEDICINE, 2020, 48
  • [9] Electrocardiographic Features of Immune Checkpoint Inhibitor-Associated Myocarditis
    Song, Wenhua
    Zheng, Yi
    Dong, Mei
    Zhong, Lin
    Bazoukis, George
    Perone, Francesco
    Li, Guangping
    Ng, Chi Fai
    Baranchuk, Adrian
    Tse, Gary
    Liu, Tong
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (02)
  • [10] Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis
    Salem, Joe-Elie
    Allenbach, Yves
    Vozy, Aurore
    Brechot, Nicolas
    Johnson, Douglas B.
    Moslehi, Javid J.
    Kerneis, Mathieu
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24): : 2377 - 2379